kohlpharma GmbH, Abacus Medicine A/S, axicorp Pharma GmbH secures contract for Pharmaceutical Products-Completion of a non-exclusive discount agreement according to Section 130a (8) SGB V for the active ingredient Aripiprazole, (exclusively production of a depot injection injection pension f d z 01022023-31012025

Germany, Jan. 30 -- Germany based kohlpharma GmbH, Abacus Medicine A/S, axicorp Pharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical Products-Completion of a non-exclusive discount agreement according to Section 130a (8) SGB V for the active ingredient Aripiprazole, (exclusively production of a depot injection injection pension f d z 01022023-31012025. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....